
Cilast 250mg/250mg Injection
Marketer
Unitek
Salt Composition
Imipenem (250mg) + Cilastatin (250mg)
Overview Cilast 250mg/250mg Injection
Combiflox 250mg/250mg Injection, a dual-antibiotic formulation, combats severe bacterial infections. Administered only by a healthcare provider, it targets infectious microorganisms to curtail further spread. Complete the prescribed dosage, even with symptom improvement, and attend all scheduled appointments. Common side effects include nausea, vomiting, diarrhea, and skin rashes; injection site reactions (redness, swelling, pain) are also possible, usually resolving spontaneously. Severe side effects or allergic reactions (rash, itching, swelling, breathing difficulties) necessitate immediate medical attention. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from operating vehicles if drowsiness or dizziness occurs.
Primary Ingredients of Cilast 250mg/250mg Injection
No text provided to rephrase.
Uses of Cilast 250mg/250mg Injection
Life-threatening bacterial infections
Major Benefits of Cilast 250mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cilast 250mg/250mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Cilast 250mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cilast 250mg/250mg Injection works:
Imipenem/Cilastatin 250mg/250mg Injection combines the antibiotic imipenem with the dehydropeptidase I inhibitor, cilastatin. Imipenem's antibacterial action disrupts bacterial cell wall synthesis, crucial for bacterial viability. Cilastatin safeguards imipenem's efficacy by inhibiting dehydropeptidase I, an enzyme that otherwise rapidly metabolizes imipenem. This dual action ensures sustained imipenem activity within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cilast 250mg/250mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Cilast 250mg/250mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingSAFE IF PRESCRIBED
Administration of Cilast 250mg/250mg Injection while breastfeeding appears to pose minimal risk. Available data from human studies indicate negligible danger to the infant.
DrivingUNSAFE
Administering Cilast 250mg/250mg Injection may induce adverse reactions impacting driving aptitude. Certain drug-related side effects, including hallucinations (visual, auditory, or sensory), can impair driving capabilities in some individuals.
KidneyCAUTION
For individuals with impaired kidney function, administering Cilast 250mg/250mg Injection requires careful consideration. Dosage modification for Cilast 250mg/250mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data on Cilast 250mg/250mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Cilast 250mg/250mg Injection :
Should you forget a Cilast 250mg/250mg Injection dose, seek medical advice.
Facts to Know About Cilast 250mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
